16
Participants
Start Date
February 17, 2021
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
(64Cu)-NOTA-PSMAi-PEG-Cy5.5-C' dot tracer, or (89Zr)-DFO-PSMAi-PEG-Cy5.5-C' dots
Patients will be injected with approximately 6-7 mCi (+/- 10%) of 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots or 89Zr-DFO-PSMAi-PEG-Cy5.5-C' dots, up to 48 hours before surgery.
PET/MRI/fluorescence imaging
Imaging will be performed using the GE Signa PET/MRI.
Blood and urine sampling
Staff will perform the IV blood draws and collect urine samples
laparoscopic radical prostatectomy and bilateral pelvic LN dissection or a salvage lymph node dissection
Surgery will be performed within 24 h of the third PET/MRI scan.
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
NOT_YET_RECRUITING
Weill Cornell Medicine, New York
Cornell University/Weill Cornell Medical Center
UNKNOWN
National Cancer Institute (NCI)
NIH
Memorial Sloan Kettering Cancer Center
OTHER